Product Information

FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.5252 per EA under NDC 69097097307. Its NADAC has been published 203 times since Sep 9, 2020.

FDA first approved this application on Jul 9, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB

Fosinopril Sodium and Hydrochlorothiazide
$0.5252per EA

Strength

20; 12.5 mg/1; mg/1

Manufacturer

Cipla USA Inc.

NDC

69097097307

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA090228

FDA Approved

7/9/2009

TE Code

AB

On Market Since

7/24/2020

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 203 times since Sep 9, 2020, and over the history we have for it it has declined 26.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5252 per EA
All-time high$0.7170 (Jun 16, 2021)
All-time low$0.4107 (Oct 18, 2023)
52-week high$0.6291
52-week low$0.4313
Median price$0.5993
Average price$0.5875
Largest weekly change-36.5% (Oct 18, 2023)
Weeks tracked203
Tracking sinceSep 9, 2020

Price History

1W

+8.5%

1M

+8.5%

3M

+20.9%

6M

+1.8%

1Y

-6.8%

3Y

-18.8%

5Y

-26.7%

All

-26.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Cipla USA Inc., is $0.5252 per EA (NDC 69097097307), effective Aug 19, 2026.

How has the price of FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 26.7%. It has been tracked across 203 weekly CMS publications since Sep 9, 2020.

What are the highest and lowest recorded NADAC prices for FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

Since Sep 9, 2020, the NADAC for FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.4107 (Oct 18, 2023) to a high of $0.7170 (Jun 16, 2021), with a median of $0.5993 per EA.

Are there cheaper alternatives to FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 69097097307) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.